CpG island hypermethylation profile in the serum of men with clinically localized and hormone refractory metastatic prostate cancer

被引：59

作者：

Bastian, Patrick J. ^{[1
,2
,3
]}

Palapattu, Ganesh S. ^{[2
,3
]}

Yegnasubramanian, Srinivasan ^{[2
,3
,6
]}

Rogers, Craig G. ^{[2
,3
]}

Lin, Xiaohui ^{[4
]}

Mangold, Leslie A. ^{[2
,3
]}

Trock, Bruce ^{[2
,3
]}

Eisenberger, Mario A. ^{[2
,3
,4
,7
]}

Partin, Alan W. ^{[2
,3
]}

Nelson, William G. ^{[2
,3
,4
,5
,6
,7
]}

机构：

[1] Univ Munich, Univ Klinikum Grosshadern, Urol Klin & Poliklin, D-81377 Munich, Germany

[2] Johns Hopkins Univ, Sch Med, James Buchanan Brady Urol Inst, Baltimore, MD USA

[3] Johns Hopkins Univ, Sch Med, Dept Urol, Baltimore, MD USA

[4] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD USA

[5] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD USA

[6] Johns Hopkins Univ, Sch Med, Dept Pharmacol, Baltimore, MD USA

[7] Johns Hopkins Univ, Sch Med, Sydney Kimmel Comprehens Canc Ctr, Baltimore, MD USA

来源：

JOURNAL OF UROLOGY | 2008年 / 179卷 / 02期

关键词：

prostate; prostatic neoplasms; tumor markers; biological; glutathione S-transferase pi; neoplasm recurrence; local;

D O I：

10.1016/j.juro.2007.09.038

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

Purpose: We have noted that hypermethylation at GSTP1 in the preoperative serum of men with localized prostate cancer predicts early prostate specific antigen failure following surgical treatment. In this study we investigated the hypermethylation profile of several genes in the serum of men with localized and hormone refractory prostate cancer. Materials and Methods: We assayed the serum of 192 men with clinically localized prostate cancer and 18 with hormone refractory metastatic disease. A total of 35 serum samples from patients with negative prostate biopsy served as a negative control. CpG Island hypermethylation status of certain genes was assessed, including MDR1, EDNRB, CD44, NEP, PTGS2, RASSF1A, RAR-beta and ESR1. The results of hypermethylation at GSTP1 were included from a previous study. Results: CpG island hypermethylation at MDR1 was positive in 38.2% of cases without PSA recurrence and in 16.1% of those with biochemical recurrence after radical prostatectomy. DNA hypermethylation at the remaining 7 gene loci was not detected in the serum of patients with localized prostate cancer. In serum from metastatic prostate cancer cases CpG island hypermethylation was detected at MDR1 in 15 (83.3%), EDNRB in 9 (50%), RAR-beta in 7 (38.9%), GTSP1 in 5 (27.8%) and NEP or RASSF1A in 3 (16.7%). CpG island hypermethylation at CD44, PTGS2 or ESR was not detected in any samples. All histologically normal cases were negative for CpG island hypermethylation. Conclusions: DNA hypermethylation at MDR1 was detected in cases of localized prostate cancer. CpG island hypermethylation at several gene loci was detected in men with advanced disease. No single gene was consistently observed to be hypermethylated in men with hormone refractory disease. These results suggest that the CpG island hypermethylation status of a defined panel of genes may be a useful biomarker in men with hormone refractory prostate cancer.

引用

页码：529 / 534

页数：6

共 50 条

[21] Clinical benefit of atrasentan for men with metastatic hormone-refractory prostate cancer metastatic to bone.
Sleep, D. J.
Nelson, J. B.
Petrylak, D. P.
Isaacson, J. D.
Carducci, M. A.
JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 249S - 249S
[22] Serum BPSA predicts prostate volume despite the presence of clinically localized prostate cancer in men undergoing prostate biopsy
Canto, EI
Singh, H
Houston, DJ
Mikolajczyk, SD
Linton, HJ
Wheeler, TM
Kadmon, D
Miles, BJ
Levitt, JM
Slawin, KM
JOURNAL OF UROLOGY, 2005, 173 (04): : 258 - 258
[23] Gene expression panel predicts metastatic-lethal prostate cancer outcomes in men diagnosed with clinically localized prostate cancer
Rubicz, Rohina
Zhao, Shanshan
Wright, Jonathan L.
Coleman, Ilsa
Grasso, Catherine
Geybels, Milan S.
Leonardson, Amy
Kolb, Suzanne
April, Craig
Bibikova, Marina
Troyer, Dean
Lance, Raymond
Lin, Daniel W.
Ostrander, Elaine A.
Nelson, Peter S.
Fan, Jian-Bing
Feng, Ziding
Stanford, Janet L.
MOLECULAR ONCOLOGY, 2017, 11 (02) : 140 - 150
[24] A CpG island hypermethylation profile of primary colorectal carcinomas and colon cancer cell lines
Lind, Guro E.
Thorstensen, Lin
Lovig, Tone
Meling, Gunn I.
Hamelin, Richard
Rognum, Torleiv O.
Esteller, Manel
Lothe, Ragnhild A.
MOLECULAR CANCER, 2004, 3 (1)
[25] A CpG island hypermethylation profile of primary colorectal carcinomas and colon cancer cell lines
Guro E Lind
Lin Thorstensen
Tone Løvig
Gunn I Meling
Richard Hamelin
Torleiv O Rognum
Manel Esteller
Ragnhild A Lothe
Molecular Cancer, 3
[26] Association between polymorphisms of methylenetetrahydrofolate reductase and aberrant CpG island hypermethylation in prostate cancer
Watanabe, Masatoshi
Hirokawa, Yoshifumi
Takagi, Akimitsu
Matsuzaki, Takeshi
Suzuki, Hiroyoshi
Sugimura, Yoshiki
Shiraishi, Taizo
CANCER RESEARCH, 2006, 66 (08)
[27] GSTP1 CpG island hypermethylation as a molecular marker in the carcinogenesis of prostate cancer
Bastian, PJ
Nakayama, M
De Marzo, AM
Nelson, WG
UROLOGE A, 2004, 43 (05): : 573 - +
[28] Aberrant CpG island hypermethylation of multiple genes in prostate cancer and prostatic intraepithelial neoplasia
Kang, GH
Lee, S
Lee, HJ
Hwang, KS
JOURNAL OF PATHOLOGY, 2004, 202 (02): : 233 - 240
[29] Safety of purified isoflavones in men with clinically localized prostate cancer
Kumar, Nagi B.
Krischer, Jeffrey P.
Allen, Kathy
Riccardi, Diane
Besterman-Dahan, Karen
Salup, Raoul
Kang, Lovellen
Xu, Ping
Pow-Sang, Julio
NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL, 2007, 59 (02): : 169 - 175
[30] Proteomic Serum Profile of Fatigued Men Receiving Localized External Beam Radiation Therapy for Non-Metastatic Prostate Cancer
Lukkahatai, Nada
Patel, Sajni
Gucek, Marjan
Hsiao, Chao-Pin
Saligan, Leorey N.
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2014, 47 (04) : 748 - +

← 1 2 3 4 5 →